ELV Elevance Health, Inc. Common Stock

NYSE · Health Care · ดูใน SEC EDGAR ↗
$399.76
ราคา · ส.ค. 21, 2026
ข้อมูลพื้นฐาน ณ วันที่ ก.ค. 15, 2026

เกี่ยวกับ Elevance Health, Inc. Common Stock ภาพรวมบริษัทจาก Wikipedia

Elevance Health, Inc. is an American health insurance company. Prior to June 2022, Elevance Health was named Anthem, Inc. The company is the world's seventh largest healthcare company based on revenue. Its services include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans through affiliated companies such as Anthem Blue Cross and Blue Shield, Anthem Blue Cross in California, Wellpoint, and Carelon. It is the largest for-profit managed health care company in the Blue Cross Blue Shield Association. As of 2022, the company had 46.8 million members within its affiliated companies' health plans.

อ่านเพิ่มเติม

Elevance Health, Inc. is an American health insurance company. Prior to June 2022, Elevance Health was named Anthem, Inc. The company is the world's seventh largest healthcare company based on revenue. Its services include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans through affiliated companies such as Anthem Blue Cross and Blue Shield, Anthem Blue Cross in California, Wellpoint, and Carelon. It is the largest for-profit managed health care company in the Blue Cross Blue Shield Association. As of 2022, the company had 46.8 million members within its affiliated companies' health plans.

Based on its 2021 revenues, the company ranked 20th on the 2022 Fortune 500. In 2023, the company's seat in Forbes Global 2000 rankings was 78. Carelon Global Solutions, Elevance Health's Business Process Outsourcing (BPO)/Shared Services subsidiary, serves the group's offshore and customer service management. It operates sites in India, Puerto Rico, Philippines, and the United States.

History

Anthem

In 1946, Anthem began in Indianapolis, Indiana, as Mutual Hospital Insurance Inc. and Mutual Medical Insurance Inc. The companies grew significantly, controlling 80% of the medical insurance market in Indiana by the 1970s.

In 1972, the two firms, then known as Blue Cross of Indiana and Blue Shield of Indiana, entered into a joint operating agreement.

In 1985, the two companies merged into Associated Insurance Companies, Inc,, later called, The Associated Group, a holding company, but usage of the name "Anthem" persisted. In 1989, the company purchased American General Insurance Co. for $150 million and in 1991, it acquired The Shelby Insurance Co., based in Shelby, Ohio, for $125 million. In 1989, The Associated Group founded Acordia, a brokerage that sold and serviced insurance and employee benefit programs.

In 1993, Acordia acquired American Business Insurance for $130 million and the Federal Kemper Insurance Company for $100 million. The Associated Group merged with Southeastern Mutual Insurance Company, the operator of Blue Cross and Blue Shield of Kentucky. In 1994, it sold Raffensperger, Hughes & Co., Inc., Indiana's largest investment bank, to National City Corp.

In 1995, The Associated Group acquired Community Mutual Insurance, a provider of Blue Cross and Blue Shield insurance plans in Ohio with over 1.9 million policy holders), then set up Anthem Blue Cross and Blue Shield. In 1996, The Associated Group changed its name to Anthem Insurance Company. In August 1997, Anthem acquired Blue Cross and Blue Shield of Connecticut. It also sold Acordia to management.

In 1999, Anthem acquired Blue Cross and Blue Shield of New Hampshire and Blue Cross and Blue Shield of Colorado and Nevada, using debt financing. The acquisitions made since 1996 added 850,000 policy holders. Among its customer base were 2.4 million PPO and 964,000 HMO enrollees.

In 2000, Anthem acquired Blue Cross Blue Shield of Maine. The Gramm-Leach-Bliley Act of 1999 made it possible for Anthem to undergo demutualization and become a public company via an initial public offering, which made it the fourth largest public managed health care company in the United States.

In 2002, Anthem acquired Trigon Healthcare of Virginia, a Blue Cross and Blue Shield plan, the largest insurer in Virginia, for $4.04 billion. Anthem Insurance Company reached 11.9 million members.

Blue Cross of California

Blue Cross of California was the predecessor of WellPoint Health Network Inc.

In 1982, Blue Cross of California was founded with the consolidation of Blue Cross of Northern California (established in 1936) and Blue Cross of Southern California (established in 1937).

In 1992, WellPoint was formed to operate Blue Cross of California's managed care business. In January 1993, Blue Cross of California spun off its managed care business into a publicly traded entity, WellPoint Health Networks Inc. Blue Cross of California retained an 80% interest and voting control.

In 1996, Blue Cross of California restructured to a for-profit corporation, designating WellPoint Health Networks Inc. as the parent organization. In April 1996, WellPoint completed its acquisition of Massachusetts Mutual Life Insurance Company's group life and health insurance subsidiaries for approximately $380 million, making it the second largest publicly held managed health company in the U.S. with 4 million policyholders.

In March 1997, WellPoint acquired the group health and life businesses of John Hancock Financial for $86.7 million. With this acquisition, WellPoint expanded its presence into Michigan, Texas, and the mid-Atlantic, and gained a unit that concentrated on serving the needs of large employers.

In 2000, WellPoint acquired PrecisionRx, a mail service pharmacy fulfillment center in Texas. In March 2000, WellPoint acquired Rush Prudential Health Plans, a Chicago provider, for $204 million. In March 2001, WellPoint acquired Cerulean Companies, the parent company of Blue Cross Blue Shield of Georgia. In 2001, WellPoint offered to acquire CareFirst BlueCross BlueShield for $1.37 billion, including $119 million in bonuses to Carefirst executives. In 2003, the offer was rejected by the Maryland insurance commissioner.

In 2002, WellPoint acquired RightChoice Managed Care, a Missouri-based company that ran Blue Cross and Blue Shield for part of the state, for $1.5 billion. RightChoice also owned provider network company HealthLink. WellPoint also acquired MethodistCare of Houston, Texas and HealthLink. In 2003, WellPoint acquired Golden West Dental and Vision of Camarillo, California, and Cobalt, including Blue Cross and Blue Shield United of Wisconsin.

In November 2004, Wellpoint, Inc. was formed by the merger of Anthem Insurance Company and WellPoint Health Networks Inc. The merger was structured as Anthem acquiring WellPoint Health Networks and renaming itself WellPoint, Inc. WellPoint continued to use 'Anthem' as the brand name under which it operated. It sold its Blue Cross and Blue Shield products in 11 states.

In 2005, WellPoint acquired Alexandria, Virginia–based Lumenos, a provider of consumer-driven health care, for $185 million. Lumenos was the pioneer and market leader in consumer-driven health plans. In December, WellPoint acquired WellChoice, a New York City-based Blue Cross Blue Shield provider, for approximately $6.5 billion, making New York the 14th state in which WellPoint is a Blue Cross Blue Shield licensee.

In 2007, WellPoint acquired Chicago-based American Imaging Management, a radiology benefit management company that creates software to help physicians choose cost-effective locations for their patients to receive medical imaging tests. WellPoint also acquired Chicago-based American Imaging Management (AIM), the leading radiology benefit management company.

In January 2008, Leslie Margolin became the president of California operations. She resigned in July 2010. In 2008, WellPoint acquired Resolution Health, a firm that analyzes patient history for potential medical problems such as adverse drug interactions. In 2009, WellPoint acquired DeCare Dental, a dental insurance firm.

In 2011, WellPoint acquired CareMore, a Cerritos, California-based provider of insurance and care centers for elderly patients. In 2012, WellPoint acquired Amerigroup for $4.9 billion, anticipating significant growth due to Medicaid expansion under the Patient Protection and Affordable Care Act. In August 2012, CEO Angela Braly resigned due to pressure from investors.

On August 13, 2014, WellPoint announced it intended to change its name to Anthem, Inc., effective in December.

Anthem, Inc.

In February 2015, the company acquired Simply Healthcare Holdings, a Medicaid and Medicare managed care company based in Florida. In June 2015, Anthem made an offer to acquire Cigna for more than $54 billion in cash and stock. In February 2017, United States district court Judge Amy Berman Jackson blocked the Cigna merger on grounds of anti-competitive practices. On February 14, Cigna called off its merger agreement with Anthem.

In October 2017, Anthem announced that it would not renew its pharmacy benefit management (PBM) relationship with Express Scripts saying it had been overcharged $3 billion and that instead, Anthem would eventually handle the PBM process itself through its new IngenioRx unit. Anthem announced that it would enter a 5-year contract with CVS Health. Cigna then announced plans in March 2018 to acquire Express Scripts for $58 billion. On November 6, 2017, Gail Koziara Boudreaux was named CEO. In 2018, the company announced a $20 million expansion of its headquarters and the signing of a lease in Atlanta for its technology center. In March 2020, Anthem announced the acquisition of Beacon Health Options, and independently held behavioral health organization.

On February 2, 2021, Anthem announced the acquisition of InnovaCare Health's Puerto Rico subsidiaries including MMM Holdings, LLC ("MMM") and its Medicare Advantage (MA) plan MMM Healthcare, LLC as well as affiliated companies and Medicaid plan. In November 2021, Anthem announced the acquisition of Integra Managed Care in New York. The acquisition of the New York-based international health insurance company was completed on May 5, 2022.

On June 28, 2022, Anthem announced a change of its corporate name to Elevance Health, Inc. and also changed its stock ticker symbol from "ANTM" to "ELV".

Elevance Health

On January 23, 2023, Elevance announced that it entered a definitive agreement to acquire Blue Cross and Blue Shield of Louisiana, increasing Elevance's footprint to 15 states and adding 1.9 million new members. In 2023, Elevance announced that it would rebrand its Amerigroup business as Wellpoint starting in 2024.

As of 2025, Elevance subsidiaries Carelon Behavioral Health and Anthem Blue Cross and Blue Shield are the subject of three lawsuits in New York and Connecticut alleging that they operate ghost networks.

Subsidiaries

Elevance Health includes the following subsidiaries:

Amerigroup

District of Columbia (Medicaid)

Georgia (Medicaid)

New Mexico (Medicare Advantage)

Anthem Blue Cross

California

Blue Cross of California Partnership Plan (Medicaid)

New York (upstate)

Anthem Blue Cross Blue Shield

Colorado

Connecticut

Georgia

Indiana (includes Medicaid)

Kentucky

Anthem Blue Cross and Blue Shield Medicaid

Maine

Missouri (excluding 30 counties in the Kansas City area)

Nevada

Anthem Blue Cross and Blue Shield Healthcare Solutions (Medicaid)

New Hampshire

New York (downstate)

HealthPlus (Medicaid)

Ohio

Virginia (excluding Alexandria City, Arlington County, Falls Church City, and parts of Fairfax County)

HealthKeepers (Medicaid)

Wisconsin

Carelon Behavioral Health

Carelon Behavioral Health of California

Carelon Behavioral Health of Kansas

Carelon Health of Pennsylvania

Carelon Global Solutions (Business Process Outsourcing/Shared Services)

Freedom Health

Florida

Golden West Dental & Vision

California

HealthSun

Florida

MMM

Puerto Rico

Optimum Healthcare

Florida

Simply Healthcare

Florida

UniCare

West Virginia

WellPoint

Arizona (Medicare Advantage)

Iowa (Medicaid and Medicare Advantage)

Maryland (Medicaid)

Massachusetts (government employees)

New Jersey (Medicaid and Medicare Advantage)

Tennessee (Medicaid and Medicare Advantage)

Texas (Medicaid and Medicare Advantage)

Washington (Medicaid and Medicare Advantage)

Joint ventures

Elevance Health operates joint ventures including:

Anthem | MaineHealth (with MaineHealth)

Maine

Blue Medicare Advantage (with Independence Blue Cross)

Pennsylvania

Colorado Community Health Alliance (with Centura Health, Physician Health Partners and Primary Physician Partners)

Colorado

Healthy Blue Kansas (with Blue Cross and Blue Shield of Kansas and Blue Cross and Blue Shield of Kansas City)

Kansas

Healthy Blue Louisiana (with Blue Cross Blue Shield of Louisiana)

Louisiana

Summit Community Care

Arkansas

Centers Plan for Healthy Living

New York, Florida

Quality of care

In 2011, in the category of "Meeting National Standards of Care," California's state patient advocacy office gave Anthem a rating of 2 out of 4 stars. In 2014, it received 3 out of 4 stars in the same category. In 2022, twenty-one of Elevance Health's affiliated Medicaid plans earned accreditation for health equity from the National Committee for Quality Assurance (NCQA).

Controversies

Charitable donations

In 2007, WellPoint pledged to spend $30 million over three years, through the company's charitable foundation, to help the uninsured. In March 2010, the Los Angeles Times reported that WellPoint's tax records and website showed that the company had given only $6.2 million by 2009. The company said that the foundation had indeed fulfilled its $30-million commitment by mid-2009, but refused to provide any financial details to support its claim.

2007 DMHC investigation

In 2007, the California Department of Managed Health Care (DMHC) investigated Anthem's policies for revoking (rescinding) health care insurance policies. The DMHC randomly selected 90 instances where Anthem canceled the insurance of policy holders who had been diagnosed with costly or life-threatening illnesses, to find how many of these cancellations were legal. The agency concluded that all these cancellations were illegal.

In July 2008, Anthem Blue Cross agreed to a settlement with the California Department of Managed Health Care; however in doing so, WellPoint did not officially admit liability. To resolve allegations of improper policy rescissions (cancellations), WellPoint paid $10 million and reinstated plans for 1,770 policy-holders who were affected by cancelled policies. The company also agreed to provide compensation for any medical debts incurred by these policy-holders.

2010 Reuters exposé

In April 2010, Reuters alleged that Wellpoint "using a computer algorithm, identified women recently diagnosed with breast cancer and then singled them out for cancellation of their policies." The software used immediately triggered fraud investigation for those recently diagnosed with the disease as the company searched for some pretext to drop their policies. Wellpoint argued that its algorithm was scanning for diagnostic codes for conditions that patients might have known about during the insurance application. The story not only caused considerable public outrage, but it also led Secretary of Health and Human Services, Kathleen Sebelius, and President Barack Obama, to call on WellPoint to end the practice.

In 2011, Anthem began cancelling policies of members who had been paying premiums with credit cards, sometimes without calling or emailing the member ahead of time.

Opposition to healthcare reform

In August 2009, Anthem, the largest for-profit insurer in California, contacted its employees and urged them to get involved to oppose healthcare reforms proposed during the Obama administration. Consumer Watchdog, a nonprofit watchdog organization in Santa Monica, asked California Attorney General Jerry Brown to investigate its claim that WellPoint had illegally pushed workers to write to their elected officials, attend town hall meetings and enlist family and friends to ensure an overhaul that would match the firm's interests. According to Consumer Watchdog, California's labor code directly prohibits coercive communications, including forbidding employers from controlling, coercing or influencing employees' political activities or affiliations. WellPoint had not been contacted by the California attorney general and had not seen any complaint.

Through 2010 and into 2011, WellPoint senior executives met monthly with executives of other major health insurers to blunt the effect of the Patient Protection and Affordable Care Act.

Premium increases in Maine

In 2009, Anthem Health Plans of Maine, a WellPoint subsidiary, sued the state of Maine for the right to increase premiums further. Since Maine licenses insurance companies through its Bureau of Insurance, Anthem needed the state's permission to raise rates. The Court disagreed with Anthem and found that, unlike with other forms of insurance, the Maine Insurance Code does not require the Superintendent to consider profits.

Rate increases in California

In February 2010, WellPoint announced that rates would increase on some Anthem Blue Cross individual policies in California by as high as 39%. The announcement resulted in an investigation by regulators from the Federal and California governments. Anthem Blue Cross gained worldwide media attention and became a poster child for the problem of rising cost of health care in the U.S. The rate increase came one year after Anthem had raised rates 68% on individual policy holders.

To explain the rate increases, some which were four times the rate of medical inflation, Anthem said the company had experienced a death spiral: the company claimed that with increased unemployment and declining wages, healthy customers dropped their insurance policies. Consequently, the remaining risk pool became sicker and thus more expensive to insure; and, in turn, prices were forced up and pushed more people out of the market.

In response to the outrage from politicians and consumers, Anthem postponed the rate increase until May 1, 2010.

Senator Dianne Feinstein of California proposed giving the Federal government of the United States authority to block insurance premium hikes that it considers to be "unjustified".

WellPoint cost reclassification

On March 17, 2010, WellPoint announced it was reclassifying some of its administrative costs as medical care costs in order to meet loss ratio requirements under the Patient Protection and Affordable Care Act, which requires insurers to spend at least 80% or 85% of customer premiums on health care services, depending on the type of plan.

2009–2010 data breach

In June 2010, Anthem sent letters to 230,000 customers in California warning them that their personal data might have been accessed online via a data breach. After a routine upgrade in October 2009, a third-party vendor stated that all security measures had been properly reinstated, when in fact they had not. As a result, personal information of thousands of coverage applicants who were under the age of 65 was exposed in the open. After a Los Angeles-area woman found that her application for coverage was publicly available, she filed a class action lawsuit against Anthem. While gathering evidence for the proceeding, the woman's lawyers downloaded some confidential customer information from Anthem's website and alerted Anthem about the breach. According to the lawyers, confidential information had remained exposed for five months. Greg Zoeller, Indiana's Attorney General, filed a lawsuit against the company seeking $300,000 in civil penalties for the company alleged failure to notify its consumers about the breach.

Denial of benefits for cancer treatment

In May 2014, Anthem Blue Cross refused to pay for the hospitalization of a Sonoma County, California man for stage four cancers, although he had paid Anthem over $100,000 in premiums. Anthem ended up paying for coverage following public outcry.

2015 data breach

On February 4, 2015, Anthem, Inc. disclosed that criminal hackers had broken into its servers and potentially stolen over 37.5 million records that contain personally identifiable information from its servers. According to Anthem, Inc., the data breach extended into multiple brands Anthem, Inc. uses to market its healthcare plans, including, Anthem Blue Cross, Anthem Blue Cross and Blue Shield, Blue Cross and Blue Shield of Georgia, Empire Blue Cross and Blue Shield, Amerigroup, Caremore, and UniCare. Healthlink was also victimized. Anthem says the medical information and financial data was not compromised. Anthem has offered free credit monitoring in the wake of the breach. According to Bloomberg News, China may be responsible for this data breach. Michael Daniel, chief adviser on cybersecurity for President Barack Obama, said he would be changing his own password. About 80 million company records were hacked, stoking fears that the stolen data could be used for identity theft. The compromised information contained names, birthdays, medical IDs, social security numbers, street addresses, e-mail addresses, employment information and income data. In June 2017, Anthem agreed to spend $115M to settle allegations that it failed to adequately protect the data of its clients, the sum was to be spent on two years of services to protect victims from identity theft. In 2019, two Chinese nationals were indicted for the breach.

"Avoidable ER program"

Beginning in 2015, Anthem has been implementing and expanding its "avoidable ER program" which means not reimbursing ER visits when the cause is not covered by the company. A few patients found out that they had been stuck with bills of over $10,000 that Anthem refused to reimburse. According to a 2013 report by the Journal of the American Medical Association, 87 percent of patients initially triaged as non-urgent ended up with a diagnosis that constituted an emergency. Critics derided the scheme, citing that it was unlawful by federal law to cover a person based on diagnosis, not symptoms. It was also considered unsafe, as it pressured patients to diagnose themselves before going to the ER.

Neglecting complaints

In 2017, the California Department of Managed Health Care fined the company $5 million for untimely response to consumer complaints. In 2019, this was settled at $2.8 million.

2019 lawsuit for coercive direct payments

In 2019, Sovereign Health pressed charges against Anthem, alleging that it was using direct payments to compel them to join Anthem's network under unfavorable terms. Sovereign owns facilities that treat people with addiction and mental health problems.

Diagnostics fraud

In March 2020, Anthem was sued by the Department of Justice. The lawsuit alleges that Anthem had submitted inaccurate diagnostics data in order to obtain increased Medicare reimbursements. In October 2022, a judge ordered Anthem to face the lawsuit.

Medicare Advantage star rating

In January 2024, Elevance Health filed a lawsuit with the Department of Health and Human Services (HHS) challenging changes in the Medicare Advantage star rating methodology. Star ratings are tied to key bonus payouts, and due to the new rating system in 2024 ratings have significantly decreased.

Finances

For the fiscal year 2017, Anthem reported earnings of US$3.843 billion, with an annual revenue of US$90.039 billion, an increase of 6.1% over the previous fiscal cycle. Anthem's shares traded at over $183 per share, and its market capitalization was valued at over US$69.1 billion in October 2018.

Recognition

The company was featured on the S&P Dow Jones Sustainability Index from 2018 to 2022, was named by Fortune as one of the 100 Best Companies to Work For, and was included on the Corporate Equality Index's list of Best Places to Work for LGBTQ Equality from 2015 to 2022.

แหล่งที่มา: Wikipedia (ภาษาอังกฤษ), CC BY-SA 4.0 · ดูบน Wikipedia ↗

Wikidata ↗

ELV ภาพรวมหุ้น ราคา, มูลค่าหลักทรัพย์ตามราคาตลาด, P/E, EPS, ROE, อัตราส่วนหนี้สินต่อทุน, ช่วงราคา 52 สัปดาห์

ราคา
$399.76
มูลค่าตลาด
$88.24B
P/E (TTM)
15.9
EPS (TTM)
$25.21
รายได้ (TTM)
$199.12B
อัตราเงินปันผล
1.7%
ROE
13.3%
D/E หนี้สิน/ทุน
0.7
ช่วง 52 สัปดาห์
$275 – $436

ELV กราฟราคาหุ้น OHLCV รายวันพร้อมตัวชี้วัดทางเทคนิค — แพน ซูม และปรับแต่งมุมมองของคุณ

ผลการดำเนินงาน 10 ปี แนวโน้มรายได้ กำไรสุทธิ อัตรากำไร และ EPS

รายได้และกำไรสุทธิ $199.12B
10-point trend, +134.6%
2016-12-31 2025-12-31
EPS $25.21
10-point trend, +173.7%
2016-12-31 2025-12-31
กระแสเงินสดอิสระ $3.17B
10-point trend, +21.1%
2016-12-31 2025-12-31
อัตรากำไร 2.8%

การประเมินมูลค่า อัตราส่วน P/E, P/S, P/B, EV/EBITDA — หุ้นมีราคาแพงหรือถูก?

ตัวชี้วัด
แนวโน้ม 5 ปี
ELV
ค่ามัธยฐานของกลุ่มอุตสาหกรรม
P/E (TTM)
5-point trend, -25.2%
15.9
33.8
P/S (TTM)
5-point trend, -51.9%
0.4
0.7
P/B
5-point trend, -43.3%
2.0
3.2
EV / EBITDA
5-point trend, -22.9%
12.7
Price / FCF (ราคาต่อกระแสเงินสดอิสระ)
5-point trend, +58.3%
27.8

ความสามารถในการทำกำไร อัตรากำไรขั้นต้น, อัตรากำไรจากการดำเนินงาน และอัตรากำไรสุทธิ; ROE, ROA, ROIC

ตัวชี้วัด
แนวโน้ม 5 ปี
ELV
ค่ามัธยฐานของกลุ่มอุตสาหกรรม
Operating Margin (อัตรากำไรจากการดำเนินงาน)
5-point trend, -33.0%
3.6%
Net Profit Margin (อัตรากำไรสุทธิ)
5-point trend, -35.5%
2.8%
0.82%
ROA
5-point trend, -28.4%
4.8%
2.2%
ROE
5-point trend, -21.8%
13.3%
6.2%
ROIC
5-point trend, -17.9%
8.0%

สุขภาพทางการเงิน หนี้สิน, สภาพคล่อง, ความสามารถในการชำระหนี้ — ความแข็งแกร่งของงบดุล

ตัวชี้วัด
แนวโน้ม 5 ปี
ELV
ค่ามัธยฐานของกลุ่มอุตสาหกรรม
Debt / Equity (หนี้สินต่อทุน)
5-point trend, +14.3%
0.7
99.7
Current Ratio (อัตราส่วนสภาพคล่อง)
5-point trend, +4.8%
1.5
1.6
Quick Ratio (อัตราส่วนเงินสด)
5-point trend, +65.3%
0.2

การเติบโต การเติบโตของรายได้, EPS และกำไรสุทธิ: YoY, CAGR 3 ปี, CAGR 5 ปี

ตัวชี้วัด
แนวโน้ม 5 ปี
ELV
ค่ามัธยฐานของกลุ่มอุตสาหกรรม
Revenue YoY (รายได้ YoY)
5-point trend, +43.6%
12.5%
Revenue CAGR 3Y (CAGR รายได้ 3 ปี)
5-point trend, +43.6%
8.3%
Revenue CAGR 5Y (CAGR รายได้ 5 ปี)
5-point trend, +43.6%
10.3%
EPS YoY
5-point trend, +1.0%
-1.8%
Net Income YoY (กำไรสุทธิ YoY)
5-point trend, -8.1%
-5.3%

ตัวชี้วัดต่อหุ้น EPS, มูลค่าตามบัญชีต่อหุ้น, กระแสเงินสดต่อหุ้น, เงินปันผลต่อหุ้น

ตัวชี้วัด
แนวโน้ม 5 ปี
ELV
ค่ามัธยฐานของกลุ่มอุตสาหกรรม
EPS (Diluted) (EPS (ปรับลด))
5-point trend, +1.0%
$25.21

ประสิทธิภาพของเงินทุน อัตราหมุนเวียนสินทรัพย์, อัตราหมุนเวียนสินค้าคงคลัง, อัตราหมุนเวียนลูกหนี้

ตัวชี้วัด
แนวโน้ม 5 ปี
ELV
ค่ามัธยฐานของกลุ่มอุตสาหกรรม
Payout Ratio (อัตราการจ่ายเงินปันผล)
5-point trend, +49.3%
27.0%

เงินปันผล ผลตอบแทน, อัตราการจ่ายเงินปันผล, ประวัติเงินปันผล, CAGR 5 ปี

อัตราผลตอบแทนเงินปันผล
1.7%
อัตราการจ่ายเงินปันผล
27.0%
CAGR เงินปันผล 5 ปี
วันที่ไม่ได้รับสิทธิปันผลจำนวน
10 มิถุนายน 2026$1.7200
10 มีนาคม 2026$1.7200
5 ธันวาคม 2025$1.7100
10 กันยายน 2025$1.7100
10 มิถุนายน 2025$1.7100
10 มีนาคม 2025$1.7100
5 ธันวาคม 2024$1.6300
10 กันยายน 2024$1.6300
10 มิถุนายน 2024$1.6300
7 มีนาคม 2024$1.6300
5 ธันวาคม 2023$1.4800
7 กันยายน 2023$1.4800
8 มิถุนายน 2023$1.4800
9 มีนาคม 2023$1.4800
2 ธันวาคม 2022$1.2800
8 กันยายน 2022$1.2800
9 มิถุนายน 2022$1.2800
9 มีนาคม 2022$1.2800
2 ธันวาคม 2021$1.1300
9 กันยายน 2021$1.1300

ELV ความเห็นหลายต่อหลายของนักวิเคราะห์ มุมมองนักวิเคราะห์ทั้งเชิงบวกและเชิงลบ, ราคาเป้าหมาย 12 เดือน, อัพไซด์

ซื้อ 29 นักวิเคราะห์
  • ซื้อแนะนำ 7 24.1%
  • ซื้อ 12 41.4%
  • ถือ 10 34.5%
  • ขาย 0 0.0%
  • ขายแนะนำ 0 0.0%

ราคาเป้าหมาย 12 เดือน

21 นักวิเคราะห์ · 2026-08-20
ราคาเป้าหมายค่ามัธยฐาน $457.00 +14.3%
ราคาเป้าหมายค่าเฉลี่ย $449.10 +12.3%

ประวัติผลประกอบการ EPS จริงเทียบกับประมาณการ, เปอร์เซ็นต์ส่วนต่าง%, อัตราการชนะ, วันประกาศผลประกอบการครั้งถัดไป

ค่าเฉลี่ยส่วนต่าง
0.72%
งวด EPS Actual EPS คาด ส่วนต่าง
30 มิถุนายน 2026 $7.45 $6.27 1.2%
31 มีนาคม 2026 $12.58 $10.93 1.6%
31 ธันวาคม 2025 $3.33 $3.13 0.20%
30 กันยายน 2025 $6.03 $4.98 1.0%
30 มิถุนายน 2025 $8.84 $9.04 -0.20%
31 มีนาคม 2025 $11.97 $11.50 0.47%

การเปรียบเทียบกับบริษัทคู่เทียบ (อุตสาหกรรมย่อย GICS) เมตริกสำคัญเทียบกับบริษัทในกลุ่มอุตสาหกรรมเดียวกัน

Ticker มูลค่าตลาด P/E รายได้ YoY อัตรากำไรสุทธิ ROE อัตรากำไรขั้นต้น
ELV $77.37B 13.9 12.5% 2.8% 13.3%
UNH $299.08B 25.0 11.8% 2.7% 12.0%
HUM $50.90B 26.0 10.1% 0.92% 7.0%
CNC $20.24B -3.0 19.4% -3.4% -28.8% 7.3%
MOH $8.85B 19.5 11.8% 1.0% 10.9%
HQY $7.12B 34.0 9.5% 16.4% 10.1% 69.5%
ALHC $4.03B 46.1% -0.02% -0.52%
CLOV -5.1 40.3% -4.5% -26.2%
PGNY $2.14B 39.5 10.4% 4.5% 11.3% 23.6%

ปัจจัยพื้นฐานฉบับเต็ม ตัวชี้วัดทั้งหมดรายปี — งบกำไรขาดทุน, งบดุล, งบกระแสเงินสด

งบกำไรขาดทุน 13
ข้อมูล งบกำไรขาดทุน รายปีสำหรับ ELV
ตัวชี้วัด แนวโน้ม 202520242023202220212020201920182017201620152014
Revenue 12-point trend, +169.5% $199.12B $177.01B $171.34B $156.59B $138.64B $121.87B $104.21B $92.11B $90.04B $84.86B $79.16B $73.87B
Cost of Revenue 9-point trend, +21178000000.00 $21.18B $19.75B $17.29B $13.04B $10.89B $8.95B $1.99B $0 $0 · · ·
SG&A Expense 12-point trend, +78.6% $20.98B $20.02B $20.09B $17.70B $15.92B $17.45B $13.36B $14.02B $12.65B $12.56B $12.53B $11.75B
Operating Income 12-point trend, +62.9% $7.20B $7.86B $8.50B $8.28B $7.56B $6.36B $6.00B $5.43B $4.17B $4.80B $4.75B $4.42B
Interest Expense 10-point trend, +71.5% · · $1.03B $851M $798M $784M $746M $753M $739M $723M $653M $601M
Pretax Income 12-point trend, +53.6% $6.71B $7.90B $7.71B $7.60B $8.00B $6.24B $5.99B $5.07B $3.96B $4.55B $4.63B $4.37B
Income Tax 12-point trend, -42.0% $1.05B $1.93B $1.72B $1.71B $1.85B $1.67B $1.18B $1.32B $121M $2.08B $2.07B $1.81B
Net Income 12-point trend, +120.3% $5.66B $5.98B $5.99B $5.89B $6.16B $4.57B $4.81B $3.75B $3.84B $2.47B $2.56B $2.57B
EPS (Basic) 12-point trend, +171.5% $25.28 $25.81 $25.38 $24.56 $25.26 $18.23 $18.81 $14.53 $14.70 $9.39 $9.73 $9.31
EPS (Diluted) 12-point trend, +180.4% $25.21 $25.68 $25.22 $24.28 $24.95 $17.98 $18.47 $14.19 $14.35 $9.21 $9.38 $8.99
Shares (Basic) 12-point trend, -18.8% 224,000,000 231,700,000 235,900,000 240,000,000 243,800,000 250,800,000 255,500,000 258,100,000 261,500,000 262,900,000 263,000,000 275,900,000
Shares (Diluted) 12-point trend, -21.4% 224,600,000 232,900,000 237,400,000 242,800,000 246,800,000 254,300,000 260,300,000 264,200,000 267,800,000 268,100,000 272,900,000 285,900,000
EBITDA 12-point trend, +97.9% $8.74B $9.26B $10.24B $10.13B $8.79B $7.51B $6.00B $5.43B $4.18B $4.80B $4.75B $4.42B
งบดุล 26
ข้อมูล งบดุล รายปีสำหรับ ELV
ตัวชี้วัด แนวโน้ม 202520242023202220212020201920182017201620152014
Cash & Equivalents 12-point trend, +341.1% $9.49B $8.29B $6.53B $7.39B $4.88B $5.74B $4.94B $3.93B $3.61B $4.08B $2.11B $2.15B
Other Current Assets 12-point trend, +262.6% $5.34B $4.70B $5.79B $5.28B $4.65B $4.06B $3.02B $2.10B $2.25B $1.78B $1.56B $1.47B
Current Assets 12-point trend, +97.2% $63.00B $58.94B $60.03B $55.62B $51.12B $45.75B $39.03B $34.32B $36.26B $34.31B $30.86B $31.95B
PP&E (Net) 12-point trend, +140.7% $4.68B $4.65B $4.36B $4.32B $3.92B $3.48B $3.13B $2.73B $2.17B $1.98B $2.02B $1.94B
PP&E (Gross) 12-point trend, +132.0% $8.73B $8.33B $7.90B $7.12B $8.26B $7.33B $6.48B $5.55B $4.37B $4.14B $4.06B $3.76B
Accum. Depreciation 12-point trend, +122.8% $4.06B $3.68B $3.54B $2.80B $4.34B $3.84B $3.35B $2.81B $2.20B $2.16B $2.04B $1.82B
Goodwill 12-point trend, +65.9% $28.34B $28.28B $25.32B $24.38B $24.23B $21.69B $20.50B $20.50B $19.23B $17.56B $17.56B $17.08B
Intangibles 12-point trend, +40.7% $11.20B $12.09B $10.27B $10.31B $10.62B $9.40B $8.67B $9.01B $8.37B $7.96B $8.16B $7.96B
Other Non-current Assets 12-point trend, +350.9% $2.31B $2.14B $1.97B $1.69B $1.72B $1.44B $1.35B $758M $565M $468M $485M $512M
Total Assets 12-point trend, +97.0% $121.49B $116.89B $108.93B $102.75B $97.46B $86.61B $77.45B $71.57B $70.54B $65.08B $61.72B $61.68B
Accounts Payable 12-point trend, +100.5% $7.32B $6.93B $6.91B $5.61B $4.97B $5.49B $4.20B $4.96B $5.02B $4.01B $3.32B $3.65B
Short-term Debt 12-point trend, -62.5% $150M $365M $225M $265M $275M $0 $700M $1.15B $1.27B $440M $540M $400M
Current Liabilities 12-point trend, +118.8% $41.03B $40.58B $41.79B $39.70B $34.88B $29.45B $23.53B $21.96B $23.36B $21.29B $19.09B $18.75B
Capital Leases 5-point trend, -38.8% $529M $658M $685M $751M $864M · · · · · · ·
Deferred Tax 12-point trend, -28.4% $2.11B $2.15B $1.97B $2.02B $2.81B $2.02B $2.23B $1.96B $1.73B $2.78B $2.63B $2.95B
Other Non-current Liabilities 12-point trend, +240.4% $3.53B $3.33B $1.74B $1.56B $1.68B $1.81B $1.42B $1.18B $925M $884M $994M $1.04B
Total Liabilities 12-point trend, +107.0% $77.47B $75.46B $69.52B $66.42B $61.29B $53.42B $45.73B $43.03B $44.04B $39.98B $38.67B $37.42B
Long-term Debt 12-point trend, +117.8% $31.90B $30.87B $24.89B $23.85B $22.76B $20.04B $19.39B $18.07B $18.66B $15.29B $15.32B $14.64B
Total Debt 12-point trend, +111.5% $32.05B $31.23B $25.12B $24.11B $23.03B $20.04B $20.09B $19.21B $19.93B $15.73B $15.86B $15.15B
Common Stock 12-point trend, -25.9% $2M $2M $2M $2M $2M $3M $3M $3M $3M $3M $3M $3M
Paid-in Capital 12-point trend, -11.2% $8.94B $8.91B $8.87B $9.08B $9.15B $9.24B $9.45B $9.54B $8.55B $8.81B $8.56B $10.06B
Retained Earnings 12-point trend, +152.5% $35.39B $33.55B $31.75B $29.65B $27.14B $23.80B $22.57B $19.99B $18.05B $16.56B $14.78B $14.01B
AOCI 12-point trend, -362.4% $-451M $-1.15B $-1.31B $-2.49B $-197M $150M $-296M $-986M $-101M $-268M $-293M $172M
Stockholders' Equity 12-point trend, +80.9% $43.88B $41.31B $39.31B $36.24B $36.09B $33.20B $31.73B $28.54B $26.50B $25.10B $23.05B $24.25B
Liabilities + Equity 12-point trend, +97.0% $121.49B $116.89B $108.93B $102.75B $97.46B $86.61B $77.45B $71.57B $70.54B $65.08B $61.72B $61.68B
Shares Outstanding 12-point trend, -17.7% 220,723,898 227,479,695 233,071,088 237,958,067 241,770,746 245,401,430 252,922,161 257,395,577 256,084,913 263,747,395 261,238,188 268,109,932
กระแสเงินสด 18
ข้อมูล กระแสเงินสด รายปีสำหรับ ELV
ตัวชี้วัด แนวโน้ม 202520242023202220212020201920182017201620152014
D&A 8-point trend, +36.6% $1.55B $1.39B $1.75B $1.68B $1.30B $1.15B $1.13B $1.13B · · · ·
Stock-based Comp 12-point trend, +63.4% $276M $191M $289M $264M $255M $283M $294M $226M $170M $165M $148M $169M
Deferred Tax 12-point trend, -1008.8% $-279M $-374M $-602M $-115M $342M $-540M $81M $91M $-1.27B $127M $-66M $31M
Amort. of Intangibles 12-point trend, +184.3% $628M $580M $885M $767M $441M $361M $338M $358M $169M $192M $230M $221M
Other Non-cash 6-point trend, -155.9% $-2.92B $-1.38B $642M $511M $377M $5.22B · · · · · ·
Operating Cash Flow 12-point trend, +27.3% $4.29B $5.81B $8.06B $8.40B $8.36B $10.69B $6.06B $3.83B $4.18B $3.27B $4.21B $3.37B
CapEx 12-point trend, +56.2% $1.12B $1.26B $1.30B $1.15B $1.09B $1.02B $1.08B $1.21B $791M $584M $638M $715M
Investing Cash Flow 12-point trend, -37.9% $-1.34B $-5.17B $-5.57B $-4.56B $-9.64B $-7.32B $-2.79B $-1.26B $-5.08B $-514M $-1.15B $-975M
Debt Issued 12-point trend, +10.8% $2.99B $7.71B $2.57B $3.07B $3.46B $2.48B $2.47B $835M $5.46B $0 $1.23B $2.70B
Net Debt Issued 12-point trend, -13.0% $844M $6.06B $665M $1.17B $2.39B $552M $1.35B $-849M $2.64B $0 $-1.47B $970M
Stock Issued 5-point trend, +0.00 · · · · · $0 $0 $1.25B $0 $0 · ·
Stock Repurchased 12-point trend, -13.1% $2.60B $2.90B $2.68B $2.32B $1.90B $2.70B $1.70B $1.69B $2.00B $0 $1.52B $3.00B
Net Stock Activity 12-point trend, +13.1% $-2.60B $-2.90B $-2.68B $-2.32B $-1.90B $-2.70B $-1.70B $-435M $-2.00B $0 $-1.52B $-3.00B
Dividends Paid 12-point trend, +218.1% $1.53B $1.51B $1.40B $1.23B $1.10B $954M $818M $776M $705M $684M $657M $481M
Financing Cash Flow 12-point trend, +4.6% $-1.74B $1.19B $-3.35B $-1.32B $423M $-2.57B $-2.27B $-2.24B $427M $-799M $-3.09B $-1.82B
Net Change in Cash 12-point trend, +113.0% $1.20B $1.83B $-861M $2.51B $-861M $804M $1.00B $325M $-466M $1.96B $-38M $565M
Free Cash Flow 12-point trend, +19.6% $3.17B $4.55B $6.76B $7.25B $7.28B $9.67B $4.98B $2.62B $3.39B $2.62B $3.48B $2.65B
Levered FCF 10-point trend, +159.1% · · $5.97B $6.59B $6.66B $9.09B $4.38B $2.06B $2.67B $2.23B $3.12B $2.30B
ความสามารถในการทำกำไร 7
ข้อมูล ความสามารถในการทำกำไร รายปีสำหรับ ELV
ตัวชี้วัด แนวโน้ม 202520242023202220212020201920182017201620152014
Operating Margin 12-point trend, -39.5% 3.6% 4.4% 5.0% 5.4% 5.4% 5.2% 5.8% 5.9% 4.6% 5.7% 6.0% 6.0%
Net Margin 12-point trend, -18.4% 2.8% 3.4% 3.5% 3.9% 4.4% 3.8% 4.6% 4.1% 4.3% 2.9% 3.2% 3.5%
Pretax Margin 12-point trend, -43.0% 3.4% 4.5% 4.5% 5.0% 5.7% 5.1% 5.7% 5.5% 4.4% 5.4% 5.9% 5.9%
EBITDA Margin 12-point trend, -26.6% 4.4% 5.2% 6.0% 6.5% 6.3% 6.2% 5.8% 5.9% 4.6% 5.7% 6.0% 6.0%
ROA 12-point trend, +12.3% 4.8% 5.3% 5.7% 6.0% 6.6% 5.6% 6.5% 5.3% 5.7% 3.9% 4.2% 4.2%
ROE 12-point trend, +25.5% 13.3% 14.8% 15.8% 16.7% 17.0% 13.6% 15.2% 13.0% 14.6% 9.9% 11.1% 10.6%
ROIC 12-point trend, +21.8% 8.0% 8.2% 10.2% 10.8% 9.8% 8.8% 9.3% 8.4% 8.7% 6.4% 6.8% 6.6%
สภาพคล่องและความสามารถในการชำระหนี้ 5
ข้อมูล สภาพคล่องและความสามารถในการชำระหนี้ รายปีสำหรับ ELV
ตัวชี้วัด แนวโน้ม 202520242023202220212020201920182017201620152014
Current Ratio 12-point trend, -10.7% 1.5 1.5 1.4 1.4 1.5 1.6 1.7 1.6 1.6 1.6 1.6 1.7
Quick Ratio 12-point trend, +101.7% 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.2 0.1 0.1
Debt / Equity 12-point trend, +16.9% 0.7 0.8 0.6 0.7 0.6 0.6 0.6 0.7 0.8 0.6 0.7 0.6
LT Debt / Equity 12-point trend, +20.5% 0.7 0.7 0.6 0.6 0.6 0.6 0.6 0.6 0.7 0.6 0.7 0.6
Interest Coverage 10-point trend, +12.2% · · 8.3 9.9 9.4 8.1 8.0 7.2 5.7 6.6 7.3 7.4
ประสิทธิภาพ 1
ข้อมูล ประสิทธิภาพ รายปีสำหรับ ELV
ตัวชี้วัด แนวโน้ม 202520242023202220212020201920182017201620152014
Asset Turnover 12-point trend, +37.5% 1.7 1.6 1.6 1.6 1.5 1.5 1.4 1.3 1.3 1.3 1.3 1.2
ต่อหุ้น 6
ข้อมูล ต่อหุ้น รายปีสำหรับ ELV
ตัวชี้วัด แนวโน้ม 202520242023202220212020201920182017201620152014
Book Value / Share 12-point trend, +119.8% $198.81 $181.62 $168.64 $152.58 $149.15 $135.28 $125.45 $110.88 $103.49 $95.17 $88.21 $90.45
Revenue / Share 12-point trend, +243.1% $886.58 $760.03 $721.74 $644.95 $561.75 $479.23 $400.36 $348.62 $336.22 $316.53 $290.06 $258.39
Cash Flow / Share 12-point trend, +62.1% $19.10 $24.94 $33.96 $34.59 $33.89 $42.03 $23.28 $14.49 $15.63 $11.95 $15.08 $11.78
Cash / Share 12-point trend, +435.8% $43.00 $36.43 $28.00 $31.04 $20.18 $23.39 $19.52 $15.28 $14.09 $15.45 $8.09 $8.03
Dividend / Share 10-point trend, +238.3% · · $6 $5 $5 $4 $3 $3 $3 $3 $2 $2
EPS (TTM) 12-point trend, +180.4% $25.21 $25.68 $25.22 $24.28 $24.95 $17.98 $18.47 $14.19 $14.35 $9.21 $9.38 $8.99
อัตราการเติบโต 10
ข้อมูล อัตราการเติบโต รายปีสำหรับ ELV
ตัวชี้วัด แนวโน้ม 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, -9.2% 12.5% 3.3% 9.4% 13.0% 13.8% · · · · · · ·
Revenue CAGR 3Y 3-point trend, -30.7% 8.3% 8.5% 12.0% · · · · · · · · ·
Revenue CAGR 5Y 10.3% · · · · · · · · · · ·
EPS YoY 5-point trend, -104.7% -1.8% 1.8% 3.9% -2.7% 38.8% · · · · · · ·
EPS CAGR 3Y 3-point trend, -89.4% 1.3% 0.97% 11.9% · · · · · · · · ·
EPS CAGR 5Y 7.0% · · · · · · · · · · ·
Net Income YoY 5-point trend, -115.3% -5.3% -0.12% 1.6% -4.3% 34.7% · · · · · · ·
Net Income CAGR 3Y 3-point trend, -114.1% -1.3% -0.97% 9.4% · · · · · · · · ·
Net Income CAGR 5Y 4.4% · · · · · · · · · · ·
Dividend CAGR 5Y 9.9% · · · · · · · · · · ·
การประเมินมูลค่า (TTM) 17
ข้อมูล การประเมินมูลค่า (TTM) รายปีสำหรับ ELV
ตัวชี้วัด แนวโน้ม 202520242023202220212020201920182017201620152014
Revenue TTM 12-point trend, +169.5% $199.12B $177.01B $171.34B $156.59B $138.64B $121.87B $104.21B $92.11B $90.04B $84.86B $79.16B $73.87B
Net Income TTM 12-point trend, +120.3% $5.66B $5.98B $5.99B $5.89B $6.16B $4.57B $4.81B $3.75B $3.84B $2.47B $2.56B $2.57B
Market Cap 12-point trend, +129.6% $77.37B $83.92B $109.91B $122.07B $112.07B $78.80B $76.39B $67.60B $57.62B $37.92B $36.43B $33.69B
Enterprise Value 12-point trend, +114.0% $99.93B $106.86B $128.50B $138.79B $130.22B $93.09B $91.54B $82.88B $73.94B $49.57B $50.18B $46.69B
P/E 12-point trend, -0.5% 13.9 14.4 18.7 21.1 18.6 17.9 16.4 18.5 15.7 15.6 14.9 14.0
P/S 12-point trend, -14.8% 0.4 0.5 0.6 0.8 0.8 0.6 0.7 0.7 0.6 0.4 0.5 0.5
P/B 12-point trend, +26.9% 1.8 2.0 2.8 3.4 3.1 2.4 2.4 2.4 2.2 1.5 1.6 1.4
P / Tangible Book 6-point trend, -52.4% 17.8 88.9 29.6 79.0 89.5 37.5 · · · · · ·
P / Cash Flow 12-point trend, +80.4% 18.0 14.4 13.6 14.5 13.4 7.4 12.6 17.7 13.8 11.8 8.9 10.0
P / FCF 12-point trend, +92.1% 24.4 18.4 16.2 16.8 15.4 8.2 15.3 25.8 17.0 14.5 10.5 12.7
EV / EBITDA 12-point trend, +8.1% 11.4 11.5 12.5 13.7 14.8 12.4 15.3 15.3 17.7 10.3 10.6 10.6
EV / FCF 12-point trend, +79.0% 31.5 23.5 19.0 19.2 17.9 9.6 18.4 31.6 21.8 18.9 14.4 17.6
EV / Revenue 12-point trend, -20.6% 0.5 0.6 0.8 0.9 0.9 0.8 0.9 0.9 0.8 0.6 0.6 0.6
Dividend Yield 12-point trend, +38.5% 2.0% 1.8% 1.3% 1.0% 0.99% 1.2% 1.1% 1.1% 1.2% 1.8% 1.8% 1.4%
Earnings Yield 12-point trend, +0.6% 7.2% 7.0% 5.3% 4.7% 5.4% 5.6% 6.1% 5.4% 6.4% 6.4% 6.7% 7.1%
Payout Ratio 12-point trend, +44.3% 27.0% 25.2% 23.3% 20.4% 18.1% 20.9% 17.0% 20.7% 18.3% 27.7% 25.7% 18.7%
Annual Payout 12-point trend, +218.1% $1.53B $1.51B $1.40B $1.23B $1.10B $954M $818M $776M $705M $684M $657M $481M

งบการเงิน งบกำไรขาดทุน, งบดุล, งบกระแสเงินสด — รายปี, 5 ปีล่าสุด

งบกำไรขาดทุน
2025-12-312024-12-312023-12-312022-12-312021-12-31
รายได้ $199.12B$177.01B$171.34B$156.59B$138.64B
อัตรากำไรจากการดำเนินงาน % 3.6%4.4%5.0%5.4%5.4%
กำไรสุทธิ $5.66B$5.98B$5.99B$5.89B$6.16B
EPS ที่ปรับลดแล้ว $25.21$25.68$25.22$24.28$24.95
งบดุล
2025-12-312024-12-312023-12-312022-12-312021-12-31
หนี้สินต่อทุน 0.70.80.60.70.6
อัตราส่วนสภาพคล่อง 1.51.51.41.41.5
อัตราส่วนเงินสด 0.20.20.20.20.1
กระแสเงินสด
2025-12-312024-12-312023-12-312022-12-312021-12-31
กระแสเงินสดอิสระ $3.17B$4.55B$6.76B$7.25B$7.28B

ข่าวล่าสุด หัวข้อข่าวล่าสุดที่กล่าวถึงบริษัทนี้

สัญญาณซื้อขาย สัญญาณซื้อ/ขายล่าสุดพร้อมราคาเข้าและอัตราส่วนความเสี่ยง/ผลตอบแทน

ตัวชี้วัดของฉัน รายการเฝ้าดูส่วนตัวของคุณ — แถวที่เลือกจากข้อมูลพื้นฐานฉบับเต็ม

📊

เลือกเมตริกที่สำคัญสำหรับคุณ — คลิก ➕ ถัดจากแถวใดก็ได้ในข้อมูลพื้นฐานฉบับเต็มด้านบน

การเลือกของคุณถูกบันทึกและจะติดตามคุณไปในทุกสัญลักษณ์หุ้น

ผู้ถือครองสถาบัน (13F) 1,772 รายงาน · $54.8B ทั้งหมด · ณ วันที่ 30 มิถุนายน 2026

สถาบันที่รายงานการถือครองหุ้นนี้ในเอกสาร SEC Form 13F รายไตรมาสของตน เฉพาะสถานะ Long; ผู้ยื่นคำร้องรายเดียวอาจปรากฏสองครั้งสำหรับสัญญาออปชันที่แยกจากกัน ขา put/call ขนาดใหญ่ที่หักล้างกันมักสะท้อนถึงการทำตลาด (market-making) หรือสินค้าคงคลังที่มีการป้องกันความเสี่ยง (hedged inventory) ไม่ใช่การเชื่อมั่นในทิศทาง

กิจกรรมของผู้ลงทุนสถาบัน — Q2 2026 เทียบกับไตรมาสก่อนหน้า
พอร์ตใหม่ ตำแหน่งที่ปิดไปแล้ว เพิ่มขึ้น ลดลง การเปลี่ยนแปลงสุทธิของจำนวนหุ้น
264 (+95 เทียบกับไตรมาสก่อน) 94 (-108 เทียบกับไตรมาสก่อน) 589 (+108 เทียบกับไตรมาสก่อน) 541 (-102 เทียบกับไตรมาสก่อน) +7.9M

เปรียบเทียบกับ Q1 2026. การยื่นแบบฟอร์ม 13F ของ SEC จะครบกำหนดภายใน 45 วันนับจากสิ้นสุดไตรมาส บวกกับระยะเวลาผ่อนผันสั้นๆ สำหรับผู้ยื่นล่าช้า — ไตรมาสที่ยังอยู่ในช่วงเวลานี้จะถูกข้ามไปเพื่อใช้คู่ที่รายงานล่าสุดอย่างสมบูรณ์

สถาบัน มูลค่า หุ้น % ของ 13F ที่ติดตาม ประเภท
VANGUARD GROUP INC $7,274,315,633 20,751,150 13.26% หุ้น
VANGUARD CAPITAL MANAGEMENT LLC $5,436,729,233 14,058,204 9.91% หุ้น
STATE STREET CORP $4,032,282,885 10,426,610 7.35% หุ้น
WELLINGTON MANAGEMENT GROUP LLP $3,179,014,962 8,220,244 5.80% หุ้น
VANGUARD PORTFOLIO MANAGEMENT LLC $2,403,277,896 6,214,356 4.38% หุ้น
Sanders Capital, LLC $2,252,711,532 5,825,024 4.11% หุ้น
Artisan Partners Limited Partnership $1,771,695,984 4,581,222 3.23% หุ้น
GEODE CAPITAL MANAGEMENT, LLC $1,712,764,692 4,448,634 3.12% หุ้น
NORGES BANK $1,531,008,381 3,958,856 2.79% หุ้น
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC $779,725,026 2,016,200 1.42% หุ้น
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $697,513,963 1,803,620 1.27% หุ้น
Grantham, Mayo, Van Otterloo & Co. LLC $654,221,093 1,691,671 1.19% หุ้น
FMR LLC $633,317,160 1,637,621 1.15% หุ้น
MANUFACTURERS LIFE INSURANCE COMPANY, THE $591,084,393 1,528,416 1.08% หุ้น
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ $588,871,451 1,522,694 1.07% หุ้น
EAGLE CAPITAL MANAGEMENT LLC $576,772,638 1,491,409 1.05% หุ้น
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $511,706,827 1,323,163 0.93% หุ้น
DIMENSIONAL FUND ADVISORS LP $511,575,693 1,322,824 0.93% หุ้น
VANGUARD FIDUCIARY TRUST CO $461,498,831 1,193,336 0.84% หุ้น
Ruane, Cunniff & Goldfarb L.P. $378,839,935 979,598 0.69% หุ้น
Brave Warrior Advisors, LLC $377,790,736 976,885 0.69% หุ้น
Newport Trust Company, LLC $369,294,278 954,915 0.67% หุ้น
1832 Asset Management L.P. $355,109,795 918,237 0.65% หุ้น
CITADEL ADVISORS LLC $293,751,600 759,578 0.54% หุ้น
Capital International Investors $290,732,899 751,772 0.53% หุ้น
MILLENNIUM MANAGEMENT LLC $281,369,666 727,561 0.51% หุ้น
BlackRock, Inc. $268,353,881 693,905 0.49% หุ้น
High Ground Investment Management LLP $262,939,273 679,904 0.48% หุ้น
CANADA PENSION PLAN INVESTMENT BOARD $261,530,030 676,260 0.48% หุ้น
Legal & General Group Plc $259,012,033 669,749 0.47% หุ้น
ACR Alpine Capital Research, LLC $254,804,222 658,869 0.46% หุ้น
Qube Research & Technologies Ltd $247,577,198 640,181 0.45% หุ้น
VICTORY CAPITAL MANAGEMENT INC $240,259,106 621,258 0.44% หุ้น
Swiss National Bank $239,610,173 619,580 0.44% หุ้น
CAPITOLIS LIQUID GLOBAL MARKETS LLC $237,525,699 614,190 0.43% หุ้น
National Pension Service $228,059,708 589,713 0.42% หุ้น
GOLDMAN SACHS GROUP INC $222,913,559 576,406 0.41% หุ้น
Sumitomo Mitsui Trust Group, Inc. $220,953,931 571,339 0.40% หุ้น
Mitsubishi UFJ Asset Management Co., Ltd. $205,911,600 532,437 0.38% หุ้น
Ninety One UK Ltd $196,567,097 508,280 0.36% หุ้น
ALLIANCEBERNSTEIN L.P. $191,531,395 654,249 0.35% หุ้น
FIRST TRUST ADVISORS LP $189,503,803 490,016 0.35% หุ้น
Vanguard Global Advisers, LLC $183,654,210 474,890 0.33% หุ้น
ENVESTNET ASSET MANAGEMENT INC $181,045,755 468,145 0.33% หุ้น
8 KNOTS MANAGEMENT, LLC $179,336,122 511,585 0.33% หุ้น
Focused Investors LLC $178,514,568 461,600 0.33% หุ้น
Nuveen Asset Management, LLC $171,198,670 464,079 0.31% หุ้น
DAVENPORT & Co LLC $171,104,235 441,940 0.31% หุ้น
VANGUARD ASSET MANAGEMENT, Ltd $167,143,159 432,196 0.30% หุ้น
Veritas Asset Management LLP $165,780,323 428,672 0.30% หุ้น
RHUMBLINE ADVISERS $161,791,876 418,359 0.29% หุ้น
California Public Employees Retirement System $157,606,784 407,537 0.29% หุ้น
FIL Ltd $157,293,146 406,726 0.29% หุ้น
MANNING & NAPIER ADVISORS LLC $142,522,435 367,297 0.26% หุ้น
Canoe Financial LP $140,577,902 363,504 0.26% หุ้น
YACKTMAN ASSET MANAGEMENT LP $131,482,399 339,985 0.24% หุ้น
BANK OF AMERICA CORP /DE/ $121,697,356 314,683 0.22% หุ้น
SUSQUEHANNA INTERNATIONAL GROUP, LLP $121,433,220 314,000 0.22% สัญญาขายล่วงหน้า
AMERIPRISE FINANCIAL INC $119,565,700 309,171 0.22% หุ้น
Swedbank AB $116,986,211 302,501 0.21% หุ้น
Assenagon Asset Management S.A. $115,776,907 299,374 0.21% หุ้น
M&G PLC $114,210,666 295,118 0.21% หุ้น
Quantinno Capital Management LP $112,935,724 292,027 0.21% หุ้น
Universal- Beteiligungs- und Servicegesellschaft mbH $112,933,654 282,040 0.21% หุ้น
SUSQUEHANNA INTERNATIONAL GROUP, LLP $107,897,670 279,000 0.20% สัญญาซื้อล่วงหน้า
BANK OF NOVA SCOTIA $101,450,881 262,330 0.18% หุ้น
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $96,843,749 330,807 0.18% หุ้น
Diamond Hill Capital Management, LLC (Investment Advisor) $96,574,989 249,722 0.18% หุ้น
Caisse de depot et placement du Quebec $94,418,969 244,147 0.17% หุ้น
Sound Shore Management Inc /CT/ $94,150,192 243,452 0.17% หุ้น
NEW YORK STATE COMMON RETIREMENT FUND $93,705,452 242,302 0.17% หุ้น
AMF Tjanstepension AB $92,093,175 238,133 0.17% หุ้น
BNP PARIBAS FINANCIAL MARKETS $91,136,405 235,659 0.17% หุ้น
MACKENZIE FINANCIAL CORP $90,587,635 234,240 0.17% หุ้น
ROYAL LONDON ASSET MANAGEMENT LTD $89,603,021 231,694 0.16% หุ้น
JANE STREET GROUP, LLC $87,130,269 225,300 0.16% สัญญาซื้อล่วงหน้า
PZENA INVESTMENT MANAGEMENT LLC $86,849,890 224,575 0.16% หุ้น
Marathon Asset Management Ltd $84,882,114 219,490 0.15% หุ้น
BNP PARIBAS ASSET MANAGEMENT Holding S.A. $84,674,534 218,950 0.15% หุ้น
BARCLAYS PLC $79,161,697 204,695 0.14% หุ้น
RENAISSANCE TECHNOLOGIES LLC $77,876,980 201,373 0.14% หุ้น
CITADEL ADVISORS LLC $77,152,635 199,500 0.14% สัญญาขายล่วงหน้า
AVIVA PLC $77,089,211 199,336 0.14% หุ้น
TD Asset Management Inc $75,328,430 194,783 0.14% หุ้น
Maple Rock Capital Partners Inc. $74,058,795 191,500 0.14% หุ้น
Mawer Investment Management Ltd. $72,431,822 187,293 0.13% หุ้น
Freestone Grove Partners LP $72,096,914 186,427 0.13% หุ้น
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM $71,577,149 185,083 0.13% หุ้น
Zurcher Kantonalbank (Zurich Cantonalbank) $71,371,408 184,551 0.13% หุ้น
Orbis Allan Gray Ltd $70,845,455 183,191 0.13% หุ้น
Jefferies Financial Group Inc. $69,850,785 180,619 0.13% หุ้น
CITADEL ADVISORS LLC $69,069,978 178,600 0.13% สัญญาซื้อล่วงหน้า
Korea Investment CORP $68,952,025 178,295 0.13% หุ้น
Harvest Portfolios Group Inc. $68,795,400 177,890 0.13% หุ้น
RAYMOND JAMES FINANCIAL INC $68,556,341 177,272 0.12% หุ้น
LPL Financial LLC $67,831,262 175,397 0.12% หุ้น
Alyeska Investment Group, L.P. $67,228,756 173,839 0.12% หุ้น
Robeco Institutional Asset Management B.V. $66,324,193 171,500 0.12% หุ้น
APG Asset Management N.V. $66,031,619 195,211 0.12% หุ้น
ADAGE CAPITAL PARTNERS GP, L.L.C. $66,009,784 170,687 0.12% หุ้น

ผู้บริหารบริษัท 92 รายชื่อผู้บริหาร · ผู้บริหาร 55 คน · กรรมการ 36 คน

ผู้บริหารภายใน บทบาท กิจกรรมล่าสุด หุ้นที่ถือครอง ซื้อ 12 เดือน ขาย 12 เดือน สุทธิ 12 เดือน
Gail Boudreaux President and CEO 17 กรกฎาคม 2026 P 171,976 2 0 $1,002,230
Brian T Griffin EVP & CEO, IngenioRx 3 พฤษภาคม 2018 M 15,863 0 0 $0
Angela F Braly Chair, President & CEO 1 มีนาคม 2012 A 476,503 0 0 $0
Brian A Sassi President & CEO Cons, EVP 7 มิถุนายน 2011 S 60,825 0 0 $0
Dijuana K Lewis Pres & CEO CHS and EVP 20 พฤษภาคม 2010 M 44,107 0 0 $0
Mark L Boxer Pres & CEO of OT&GS and EVP 4 เมษายน 2008 F 42,143 0 0 $0
Joan E Herman President & CEO Cons and EVP 7 ธันวาคม 2007 S 30,369 0 0 $0
Mark Kaye EVP & CFO 24 เมษายน 2025 S 18,977 0 0 $0
John E Gallina EVP & Chief Financial Officer 1 มีนาคม 2023 A 63,725 0 0 $0
Wayne S Deveydt EVP & Chief Financial Officer 3 มีนาคม 2016 F 57,957 0 0 $0
David C Colby Vice Chairman, CFO & EVP 4 เมษายน 2007 F 343,071 0 0 $0
Thomas R Byrd President, Anthem Specialty 26 พฤศจิกายน 2004 A 26,580 0 0 $0
Michael D Houk President, National Accounts 4 พฤศจิกายน 2004 M 18,843 0 0 $0
John M Murphy President, Specialty Business 17 พฤษภาคม 2004 A 20,806 0 0 $0
Caroline S Matthews Chief Operating Officer 1 ธันวาคม 2004 A 40,471 0 0 $0
Ronald W Penczek CAO & Controller 12 มิถุนายน 2026 S 3,740 0 1 $-148,766
Charles Morgan Kendrick JR EVP & President, Commercial 3 มีนาคม 2025 A 10,116 0 0 $0
Felicia F Norwood EVP & President,Gov Health Ben 3 มีนาคม 2025 A 31,939 0 0 $0
Ratnakar Lavu EVP, Chief Digital & Info Off 3 มีนาคม 2025 A 4,783 0 0 $0
Peter D Haytaian EVP & Pres Carelon & CarelonRx 3 มีนาคม 2025 A 26,004 0 0 $0
Blair Williams Todt EVP, CLO & CAO 3 มกราคม 2025 F 15,631 0 0 $0
Gloria M Mccarthy EVP & Chief Administrative Off 24 มีนาคม 2023 S 51,435 0 0 $0
Leah Stark EVP & CHRO 30 ธันวาคม 2021 F 12,403 0 0 $0
Jeffrey D. Alter EVP, IngenioRx & Anthem Health 1 ตุลาคม 2021 F 5,107 0 0 $0
Patel Prakash R EVP & President, DBG 4 กันยายน 2021 F 17,230 0 0 $0
Thomas C Zielinski EVP & General Counsel 3 พฤศจิกายน 2020 M 17,910 0 0 $0
Craig E Samitt EVP & President, DBG 26 กรกฎาคม 2018 M 17,274 0 0 $0
Joseph Swedish Executive Chairman 5 มีนาคม 2018 S 61,419 0 0 $0
Jacquelyn H Wolf EVP & Chief HR Officer 1 มีนาคม 2018 A 3,105 0 0 $0
Jose D. Tomas EVP & Chief HR Officer 3 มีนาคม 2017 F 23,927 0 0 $0
Samuel R Nussbaum MD EVP & Chief Medical Officer 19 พฤษภาคม 2015 M 110,973 0 0 $0
Martin B Silverstein EVP & Chief Strategy Officer 1 พฤษภาคม 2015 F 23,249 0 0 $0
Kenneth R Goulet EVP, Commercial & Specialty 2 มีนาคม 2015 A 84,281 0 0 $0
Richard C Zoretic EVP, Gov Business Division 3 มีนาคม 2014 A 53,572 0 0 $0
John Cannon EVP, GC & Chief PAO 13 ธันวาคม 2013 S 99,331 0 0 $0
Randal L Brown EVP & Chief HR Officer 4 กันยายน 2013 M 30,332 0 0 $0
Lori A Beer EVP, Specialty Businesses & IT 30 พฤษภาคม 2013 M 113,955 0 0 $0
Harlan A Levine EVP, CHS 31 สิงหาคม 2012 S 25,244 0 0 $0
Venkata R Madabhushi EVP Sr Bus & Chf Transfrmn Off 2 เมษายน 2012 A 45,237 0 0 $0
Miller Martin SVP & Chief Accounting Officer 1 มีนาคม 2011 A 29,329 0 0 $0
Fluegel M Bradley EVP, Chief Strategy Officer 5 พฤศจิกายน 2010 M 52,634 0 0 $0
Cynthia S Miller EVP & Chief Actuary 1 มีนาคม 2010 A 60,757 0 0 $0
Randall J Lewis EVP & Chief Compliance Officer 7 สิงหาคม 2009 M 13,658 0 0 $0
Jamie S Miller SVP & Chief Accounting Officer 3 มีนาคม 2008 A 25,710 0 0 $0
Alice F Rosenblatt EVP and Chief Actuary 22 มกราคม 2008 S 39,265 0 0 $0
John S Watts JR EVP 7 ธันวาคม 2007 S 108,311 0 0 $0
Marjorie W Dorr EVP 22 พฤษภาคม 2007 M 38,951 0 0 $0
Michael A Stocker EVP 23 ตุลาคม 2006 M 42,186 0 0 $0
Keith R Faller EVP 12 กันยายน 2006 M 83,290 0 0 $0
David S Helwig EVP 18 สิงหาคม 2006 M 55,055 0 0 $0

ผู้บริหารจากเอกสาร SEC Form 3/4/5; สุทธิ = เฉพาะการซื้อขายในตลาดเปิด

การถือครอง ETF ถือโดย ETF 218 ราย

น้ำหนักสะท้อนถึงการถือครองหุ้นโดยตรง (N-PORT) เท่านั้น กองทุนเลเวอเรจหรือกองทุนที่อิงตราสารอนุพันธ์อาจมีการเปิดรับความเสี่ยงจากสัญญาแลกเปลี่ยน (swap) เพิ่มเติมซึ่งไม่แสดง

กองทุน น้ำหนัก หน่วย ณ วันที่ แหล่งที่มา
IHF · iShares Trust 7.20% 221,824 SH 21 สิงหาคม 2026 รายวัน
GFGF · EA Series Trust 3.75% 3,541 NS 29 พฤษภาคม 2026 N-PORT
MDPL · Northern Lights Fund Trust IV 3.24% 5,013 NS 31 พฤษภาคม 2026 N-PORT
FXH · First Trust Exchange-Traded AlphaDE… 2.78% 64,637 NS 30 เมษายน 2026 N-PORT
ABCS · EA Series Trust 2.29% 661 NS 29 พฤษภาคม 2026 N-PORT
FEGE · RBB Fund Trust 1.92% 94,302 NS 31 พฤษภาคม 2026 N-PORT
QLTY · GMO ETF Trust 1.75% 200,065 NS 31 พฤษภาคม 2026 N-PORT
TOLL · Tema ETF Trust 1.71% 2,139 NS 31 พฤษภาคม 2026 N-PORT
SRHQ · Elevation Series Trust 1.54% 7,891 NS 30 เมษายน 2026 N-PORT
BKDV · BNY Mellon ETF Trust II 1.52% 55,921 NS 30 เมษายน 2026 N-PORT
RPV · Invesco Exchange-Traded Fund Trust 1.51% 66,138 SH 21 สิงหาคม 2026 รายวัน
RSPH · Invesco Exchange-Traded Fund Trust 1.41% 29,279 SH 21 สิงหาคม 2026 รายวัน
FHLC · FIDELITY COVINGTON TRUST 1.35% 102,444 NS 30 เมษายน 2026 N-PORT
PWV · Invesco Exchange-Traded Fund Trust 1.33% 62,208 SH 21 สิงหาคม 2026 รายวัน
IYH · iShares Trust 1.33% 129,500 SH 21 สิงหาคม 2026 รายวัน
RXL · ProShares Trust 1.26% 2,301 NS 31 พฤษภาคม 2026 N-PORT
VMAX · Lattice Strategies Trust 1.25% 1,543 NS 30 เมษายน 2026 N-PORT
VHT · VANGUARD WORLD FUND 1.22% 645,908 SH 19 สิงหาคม 2026 รายวัน
CURE · Direxion Shares ETF Trust 1.20% 4,402 NS 30 เมษายน 2026 N-PORT
IMCV · iShares Trust 1.14% 34,017 SH 21 สิงหาคม 2026 รายวัน
FTA · First Trust Exchange-Traded AlphaDE… 1.12% 38,663 NS 30 เมษายน 2026 N-PORT
SURE · AdvisorShares Trust 1.09% 1,600 NS 30 มิถุนายน 2026 N-PORT
NUDV · Nushares ETF Trust 1.09% 1,312 NS 30 เมษายน 2026 N-PORT
AVIE · AMERICAN CENTURY ETF TRUST 1.06% 278 NS 31 พฤษภาคม 2026 N-PORT
IXJ · iShares Trust 1.04% 114,143 SH 21 สิงหาคม 2026 รายวัน
MFSV · MFS Active Exchange Traded Funds Tr… 1.04% 12,508 NS 31 พฤษภาคม 2026 N-PORT
PY · Principal Exchange-Traded Funds 1.04% 5,907 NS 30 มิถุนายน 2026 N-PORT
RWL · Invesco Exchange-Traded Fund Trust … 0.97% 241,912 SH 21 สิงหาคม 2026 รายวัน
RDVI · First Trust Exchange-Traded Fund IV 0.96% 78,591 NS 30 เมษายน 2026 N-PORT
PALC · Pacer Funds Trust 0.96% 5,883 NS 30 เมษายน 2026 N-PORT
ESMV · iShares Trust 0.95% 190 SH 21 สิงหาคม 2026 รายวัน
GMOV · GMO ETF Trust 0.93% 2,152 NS 31 พฤษภาคม 2026 N-PORT
EQIN · Columbia ETF Trust I 0.90% 6,636 NS 30 เมษายน 2026 N-PORT
ROUS · Lattice Strategies Trust 0.77% 12,014 NS 30 เมษายน 2026 N-PORT
NULC · Nushares ETF Trust 0.73% 1,105 NS 30 เมษายน 2026 N-PORT
VFVA · VANGUARD WELLINGTON FUND 0.73% 15,896 SH 19 สิงหาคม 2026 รายวัน
FCTR · First Trust Exchange-Traded Fund 0.67% 991 NS 30 มิถุนายน 2026 N-PORT
VLUE · iShares Trust 0.67% 164,189 SH 21 สิงหาคม 2026 รายวัน
CVY · Invesco Exchange-Traded Fund Trust 0.65% 2,045 SH 21 สิงหาคม 2026 รายวัน
FEUS · FlexShares Trust 0.64% 1,881 NS 30 เมษายน 2026 N-PORT
FDLO · FIDELITY COVINGTON TRUST 0.62% 23,028 NS 30 เมษายน 2026 N-PORT
COPY · RBB Fund Trust 0.60% 5,260 NS 31 พฤษภาคม 2026 N-PORT
FBCV · FIDELITY COVINGTON TRUST 0.60% 2,551 NS 30 เมษายน 2026 N-PORT
IDRV · iShares Trust 0.58% 129,150 SH 21 สิงหาคม 2026 รายวัน
IMCB · iShares Trust 0.56% 24,206 SH 21 สิงหาคม 2026 รายวัน
FAB · First Trust Exchange-Traded AlphaDE… 0.55% 2,039 NS 30 เมษายน 2026 N-PORT
RDVY · First Trust Exchange-Traded Fund VI 0.54% 340,757 NS 30 มิถุนายน 2026 N-PORT
FEX · First Trust Exchange-Traded AlphaDE… 0.53% 20,983 NS 30 เมษายน 2026 N-PORT
IUS · Invesco Exchange-Traded Self-Indexe… 0.51% 12,437 SH 21 สิงหาคม 2026 รายวัน
FNDX · SCHWAB STRATEGIC TRUST 0.51% 327,388 NS 31 พฤษภาคม 2026 N-PORT